Heart Valve Onyx

• The only aortic mechanical valve with FDA, Health Canada, and CE Mark approval for Low INR of 1.5 – 2.0.
• Clinically proven to be safer with less anticoagulation resulting in >60% reduction in bleeding and no increase in thromboembolism.
• Unique material and design provide optimal hemodynamics compared with other mechanical and bioprosthetic aortic valves at ≥1 year. 

*Reduce INR after 3 months of standard therapy.

• Engineered for Exceptional Clinical Performance.

• Optimal Hemodynamics: mean gradients ≤ 4.4 mmHG across all valve sizes ≥ 25 mm¹ reducing risk of PPM.

• Optimal Length & Leaflet guards: designed to conceal pledgets, reduce risk of pannus and provide complete annular support when retaining subvalvular structure.

• The most advanced aortic valved conduit combining the On-X Aortic Valve and Vascutek Gelweave Valsalva™ Graft.
• Valsalva Graft geometry mimics the sinus of Valsalva and is designed for optimal coronary ostia reimplantation.
• On-X Aortic Valve with Conform-X Sewing Ring provides optimal hemodynamics with ease of suturing.